All You Need To Know About XEOMIN®
Why the latest botulinum toxin approved for aesthetic use in Singapore may just give Botox a run for its money.
Xeomin – the new botulinum neurotoxin.
The third botulinum neurotoxin to be approved in Singapore, XEOMIN® is said to have the lowest foreign protein content of the available botulinum neurotoxin preparations, leaving only the purified neurotoxin as the active ingredient. “In order to develop XEOMIN®, an innovative manufacturing and purification process was used to separate the complexing proteins from the pure neurotoxin, to generate a stable form of the purified neurotoxin,” explained XEOMIN® creator and Head of Botulinum Toxin Research at Merz Pharmaceuticals GmBH, Germany, Dr Jurgen Frevert.
XEOMIN® was also examined for safety and effectiveness in adults and has shown similar high clinical efficacy in glabellar frown lines as compared to onabotulinumtoxinA and is the first botulinum toxin which provides clinical efficacy data based on the stricter new US FDA criteria. Results from the first long-term repeat dosing study of XEOMIN® showed most patients experienced early onset of treatment effect and sustained efficacy. Stability studies also showed that XEOMIN® is the only botulinum neurotoxin that can be stored unopened below 25 degrees celcius.
XEOMIN® is the third botulinum neurotoxin to be approved in Singapore as an aesthetic medicine for the treatment of the glabellar frown lines. It is approved in more than 20 countries globally including the United States of America for this indication.
Will update if I decide to give this a try!
